These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3178220)

  • 1. Acylation of gelatin-agarose and the enhancement by heparin of fibronectin binding.
    Smith RL; Griffin CA
    Arch Biochem Biophys; 1988 Oct; 266(1):181-8. PubMed ID: 3178220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of heparin-binding ability of fibronectin by S-carboxamide-methylation.
    Kohama Y; Miyamoto T; Oka H; Yamamoto K; Murayama N; Tsujikawa K; Okabe M; Mimura T
    J Pharmacobiodyn; 1989 Oct; 12(10):626-33. PubMed ID: 2630632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexing of fibronectin glycosaminoglycans and collagen.
    Ruoslahti E; Engvall E
    Biochim Biophys Acta; 1980 Aug; 631(2):350-8. PubMed ID: 7407251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin glycosylation modulates fibroblast adhesion and spreading.
    Jones GE; Arumugham RG; Tanzer ML
    J Cell Biol; 1986 Nov; 103(5):1663-70. PubMed ID: 2946699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of fibronectin to gelatin and heparin: effect of surface denaturation and detergents.
    Haas R; Culp LA
    FEBS Lett; 1984 Sep; 174(2):279-83. PubMed ID: 6468662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of the binding of fibronectin to gelatin reveals the presence of different binding interactions.
    Garcia-Pardo A; Gold LI
    Arch Biochem Biophys; 1993 Jul; 304(1):181-8. PubMed ID: 8323285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy.
    Cederholm B; Wieslander J; Bygren P; Heinegård D
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4865-8. PubMed ID: 3387443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fibronectin binding to matrix components by nonenzymatic glycosylation.
    Cohen MP; Ku L
    Diabetes; 1984 Oct; 33(10):970-4. PubMed ID: 6479461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two plasma fibronectin fragments with different gelatin-binding properties.
    Griffin CA; Calaycay J; Shively JE; Smith RL
    Thromb Res; 1986 Aug; 43(4):469-77. PubMed ID: 3532418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding domains of human plasma fibronectin. pH and calcium ion modulation of fibronectin binding to DNA and heparin.
    Siri A; Balza E; Carnemolla B; Castellani P; Borsi L; Zardi L
    Eur J Biochem; 1986 Feb; 154(3):533-8. PubMed ID: 3948864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding fibronectin fragments containing cell-binding domains and devoid of hep2 and gelatin-binding domains promote human embryo fibroblast proliferation.
    Zlatopolsky AD; Chubukina AN; Berman AE
    Biochem Biophys Res Commun; 1992 Mar; 183(2):383-9. PubMed ID: 1372500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A weaker gelatin-binding affinity and increased glycosylation of amniotic fluid fibronectin than plasma fibronectin.
    Yamaguchi Y; Isemura M; Yosizawa Z; Kan M; Sato A
    Int J Biochem; 1986; 18(5):437-43. PubMed ID: 3709931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential charged amino acids in the binding of fibronectin to gelatin.
    Vuento M; Salonen E; Osterlund K; Stenman UH
    Biochem J; 1982 Jan; 201(1):1-8. PubMed ID: 7082278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of hexabrachions to heparin and DNA.
    Marton LS; Gulcher JR; Stefansson K
    J Biol Chem; 1989 Aug; 264(22):13145-9. PubMed ID: 2473987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel gelatin-binding 21 kDa protein secreted by cultured adherent cells.
    Keski-Oja J; Laiho M; Vartio T
    Biochim Biophys Acta; 1986 Jul; 882(3):367-76. PubMed ID: 3015229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.
    Wallon UM; Overall CM
    J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin gelatin-binding activity: effects of platelet thrombospondin, serum, and plasma.
    Gelder FB; Brown ST
    J Lab Clin Med; 1987 Nov; 110(5):548-57. PubMed ID: 3312442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental changes in the glycosylation and binding properties of human fibronectins. Characterization of the glycan structures and ligand binding of human fibronectins from adult plasma, cord blood and amniotic fluid.
    Köttgen E; Hell B; Müller C; Kainer F; Tauber R
    Biol Chem Hoppe Seyler; 1989 Dec; 370(12):1285-94. PubMed ID: 2619923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polylactosamine glycosylation on human fetal placental fibronectin weakens the binding affinity of fibronectin to gelatin.
    Zhu BC; Laine RA
    J Biol Chem; 1985 Apr; 260(7):4041-5. PubMed ID: 3920213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-immunoelectrophoretic analysis of heparin and gelatin binding capacity of fibronectin.
    Mazurier C; Lefevre A; Henon MP; Goudemand M
    Clin Lab Haematol; 1984; 6(2):193-7. PubMed ID: 6488741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.